Life Sciences In Action Podcast: Interview with Brad Brown, CEO of ATL Technologies on Tariffs, Manufacturing Overseas, Quality and More
January 17, 2019
The recent tariffs placed on imports have complicated the manufacturing and distribution processes for any life sciences company doing business overseas. In the pilot episode of the Life Scienes in Action Podcast Series, BioUtah president and CEO, Kelvyn Cullimore, interviews Brad Brown, CEO and chairman of ATL Technology, to discuss how the tarriffs have impacted their business. Other topics discussed include:
- Factors influencing overseas manufacturing
- The importance of quality in the manufacturing process
- Vertical integration of the manufacturing process
- What to look for when selecting a medical device manufacturer
- The importance of life sciences companies participating in BioUtah
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize